Burberry Group PLC Director/PDMR Shareholding

RNS Number : 7654B

Burberry Group PLC

01 February 2024

 

Burberry Group plc (the "Company") - Director/PDMR Shareholding

 

The Company received notification on 1 February 2024 that, following the Company's Interim Dividend payment on 26 January 2024, Alan Stewart, a Non-Executive Director, purchased 29 Ordinary Shares of 0.05 pence each in the Company ("Shares") on 30 January 2024 through participation in the Company's Dividend Reinvestment Plan ("DRIP") at a price of 1,340.0131 pence per Share.

 

1 February 2024

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 as it forms part of UK law.

 

Notification of dealing form

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Alan Stewart
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Burberry Group plc
b)	LEI	213800PE1KEFCNFR1R50
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code		Ordinary shares of 0.05 pence each     GB0031743007
b)	Nature of the transaction		Purchase of shares through participation in the Company's DRIP.
c)	Price(s) and volume(s)		Price(s) Volume(s) £13.400131   29
d)	Aggregated information   - Aggregated volume   - Price		Aggregate Price Aggregate Volume Total Cost £13.400131  29 £388.60
e)	Date of the transaction		2024-01-30
f)	Place of the transaction		London Stock Exchange (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHFLFVRFFILIIS